Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

NCT05799716 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Viremia
Bacteremia
Acute Rejection of Renal Transplant

Interventions

DRUG: IVIG

Sponsor

Shanghai Changzheng Hospital